Arvind Pandey1,2, Satyendra Chandra Tripathi3, Shirish Shukla4, Sutapa Mahata2,5, Kanchan Vishnoi2,6, Sri Prakash Misra7, Vatsala Misra8, Sankar Mitra1, Manisha Dwivedi7, Alok C Bharti2,9. 1. Department of Radiation Oncology, Houston Methodist Research Institute, Houston, Texas, USA. 2. Division of Molecular Oncology, National Institute of Cancer Prevention and Research (ICMR), Noida, Uttar Pradesh, India. 3. Clinical Cancer Prevention Research, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. 4. Department of Pathology, University of Michigan Medical School, University of Michigan, Ann Arbor, Michigan, USA. 5. Division of Pathology and Cancer Screening, Chittaranjan National Cancer Institute, Kolkata, India. 6. Department of Surgery, College of Medicine, University of Illinois at Chicago, Chicago, Illinois, USA. 7. Department of Gastroenterology, Moti Lal Nehru Medical College, Allahabad, Uttar Pradesh, India. 8. Department of Pathology, Moti Lal Nehru Medical College, Allahabad, Uttar Pradesh, India. 9. Molecular Oncology Laboratory, Department of Zoology, University of Delhi, Delhi, India.
Abstract
BACKGROUND: Localization and differential expression of STAT3 and survivin in cancer cells are often related to distinct cellular functions. The involvement of survivin and STAT3 in gastric cancer has been reported in separate studies but without clear understanding of their kinetics in cancer progression. METHODS: We examined intracellular distribution of STAT3 and survivin in gastric adenocarcinoma and compared it with normal and precancer tissues using immunoblotting and immunohistochemistry. RESULTS: Analysis of a total of 156 gastric samples comprising 61 histologically normal, 30 precancerous tissues (comprising intestinal metaplasia and dysplasia), and 65 adenocarcinomas, collected as endoscopic biopsies from treatment naïve study participants, revealed a significant (P < .001) increase in overall protein levels. Survivin expression was detectable in both cytoplasmic (90.8%) and nuclear (87.7%) compartments in gastric adenocarcinomas lesions. Precancerous dysplastic gastric lesions exhibited a moderate survivin expression (56.7%) localized in cytoplasmic compartment. Similarly, STAT3 and pSTAT3 expression was detected at high level in gastric cancer lesions. The levels of compartmentalized expression of survivin and STAT3/pSTAT3 correlated in precancerous and adenocarcinoma lesions. Although overexpression of these proteins was found associated with the tobacco use and alcohol consumption, their expression invariably and strongly correlated with concurrent Helicobacter pylori infection. Receiver operating characteristic analysis of nuclear survivin, STAT3, and pSTAT3 in different study groups showed acceptable positive and negative predictive values with area under the curve above 0.8 (P < .001). CONCLUSION: Overall, our results suggest that overall increase in survivin and STAT3 and their subcellular localization are key determinants of gastric cancer progression, which can be collectively used as potential disease biomarkers and therapeutic targets for gastric cancer.
BACKGROUND: Localization and differential expression of STAT3 and survivin in cancer cells are often related to distinct cellular functions. The involvement of survivin and STAT3 in gastric cancer has been reported in separate studies but without clear understanding of their kinetics in cancer progression. METHODS: We examined intracellular distribution of STAT3 and survivin in gastric adenocarcinoma and compared it with normal and precancer tissues using immunoblotting and immunohistochemistry. RESULTS: Analysis of a total of 156 gastric samples comprising 61 histologically normal, 30 precancerous tissues (comprising intestinal metaplasia and dysplasia), and 65 adenocarcinomas, collected as endoscopic biopsies from treatment naïve study participants, revealed a significant (P < .001) increase in overall protein levels. Survivin expression was detectable in both cytoplasmic (90.8%) and nuclear (87.7%) compartments in gastric adenocarcinomas lesions. Precancerous dysplastic gastric lesions exhibited a moderate survivin expression (56.7%) localized in cytoplasmic compartment. Similarly, STAT3 and pSTAT3 expression was detected at high level in gastric cancer lesions. The levels of compartmentalized expression of survivin and STAT3/pSTAT3 correlated in precancerous and adenocarcinoma lesions. Although overexpression of these proteins was found associated with the tobacco use and alcohol consumption, their expression invariably and strongly correlated with concurrent Helicobacter pyloriinfection. Receiver operating characteristic analysis of nuclear survivin, STAT3, and pSTAT3 in different study groups showed acceptable positive and negative predictive values with area under the curve above 0.8 (P < .001). CONCLUSION: Overall, our results suggest that overall increase in survivin and STAT3 and their subcellular localization are key determinants of gastric cancer progression, which can be collectively used as potential disease biomarkers and therapeutic targets for gastric cancer.
Authors: In Ohk Lee; Jie Hyun Kim; Yeun Jung Choi; Michael H Pillinger; Seok-Yong Kim; Martin J Blaser; Yong Chan Lee Journal: J Biol Chem Date: 2010-03-26 Impact factor: 5.157
Authors: T Ito; K Shiraki; K Sugimoto; T Yamanaka; K Fujikawa; M Ito; K Takase; M Moriyama; H Kawano; M Hayashida; T Nakano; A Suzuki Journal: Hepatology Date: 2000-05 Impact factor: 17.425
Authors: Achim Temme; Jose A Rodriguez; Sandy Hendruschk; Serap Günes; Bernd Weigle; Knut Schäkel; Marc Schmitz; Michael Bachmann; Gabriele Schackert; E Peter Rieber Journal: Cancer Lett Date: 2006-11-07 Impact factor: 8.679
Authors: Manuel Valenzuela; Denisse Bravo; Jimena Canales; Carlos Sanhueza; Natalia Díaz; Oscar Almarza; Héctor Toledo; Andrew F G Quest Journal: J Infect Dis Date: 2013-07-11 Impact factor: 5.226
Authors: Noha Said Helal; Zeinab Omran; Tarek Aboushousha; Magdy Youssef; Afkar Badawy; Mohammed A Aboul-Ezz; Mona Moussa Journal: Asian Pac J Cancer Prev Date: 2021-11-01